Navigation Links
ViGene Biosciences Introduces World's Largest Collection of Pre-Made Human Full-Length cDNA ORF and miRNA Adenoviruses
Date:11/6/2013

ROCKVILLE, Md., Nov. 6, 2013 /PRNewswire-iReach/ -- ViGene Biosciences, Inc., a leading provider of viral gene-delivery systems, today announces the launch of its world's largest collection of premade human full-length cDNA ORF and miRNA adenoviruses. The collection features over 1,240 pre-packaged human miRNA precursor adenoviruses and 6,000 pre-packaged human full-length cDNA adenoviruses. Its introduction will significantly boost high throughput drug discovery, support functional genomic studies, and make life science research more efficient and cost-effective.

(Photo:  http://photos.prnewswire.com/prnh/20131106/MN10552)

Recombinant adenoviruses are extremely efficient gene delivery systems that are widely used in human gene therapy and in vitro gene functional studies. Compared with lentiviral vector, transfection with adenovirus can reach 100% (vs. 30% with lentivirus), and protein expression can reach up to 10-20% of the total protein. Traditionally, adenoviral vector cloning and virus production requires up to 4-6 weeks, a complex and time-consuming process. The creation of this genome-wide premade adenoviruses collection that is readily available will benefit researchers who work with difficult-to-transfect primary cells and stem cells, as well as any other researchers who use full-length cDNA clones. 

"Our strength is not only the innovative technology for adenoviral vector production, but also the capability to create the most comprehensive collection of human full-length cDNA clones in the world," said Dr. Ying Chen, Vice President of Research and Development of ViGene Biosciences, Inc. "The biotech industry has been depending heavily on the MGC (Mammalian Gene Collection) for full-length cDNA clones, but the MGC only contains 13,000 full-length cDNA clones. Of the 19,000 unique genes (loci) in the human genome, we have systematically generated 18,000 full-length cDNA templates representing 18000 unique loci. Each of these cDNAs will be cloned into our adenoviral vector to produce ready-to-use adenoviruses." noted Dr. Chen. "We are thrilled to have this near-complete genome-wide premade adenovirus collection. It will greatly accelerate genome-wide high throughput drug screening and development, cell-based assays, and many aspects of gene function studies."

In addition to the adenoviral vectors, ViGene has also developed lentiviral and adeno-associated viral (AAV) vectors. Upon completion of the genome-wide adenovirus production, ViGene is excited to further transfer the same set of full-length cDNA ORFs into lentiviral vector and AAV vector to create an even broader premade virus collection. ViGene's largest premade virus collection will represent the next generation gene products for advancing life science research.

About ViGene Biosciences

Based in Rockville, Maryland, ViGene Biosciences, Inc., is a genomics tool company that develops cutting-edge and next generation life science research reagents to support high-throughput drug discovery and functional genomics.  Pioneering the development of quality adenovirus and other viral vector production, ViGene features the world's largest collection of human full-length cDNA ORF clones, miRNA clones, premade cDNA ORF and miRNA adenoviruses, and top-of-the-line custom services.  ViGene is committed to its mission "Quality Is Our Business," for providing the highest quality products, services and bringing the most innovative ideas for gene based research.For more information, please visit www.vigenebio.com or contact ViGene by email at info@vigenebio.com or call (301)-231-0600

Media Contact: Kevin Lee, ViGene Biosciences, 301-231-0600, klee@vigenebio.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE ViGene Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
3. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
4. Neurocrine Biosciences Reports First Quarter 2012 Results
5. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
8. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
9. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
10. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... May 4, 2016  It,s time for an upgrade. There are many medical recorders ... 3.5 inch LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix ... a world class manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... 2016 Valeritas Holdings, Inc. (OTCQB: ... public offering (APO). This was accomplished via a reverse ... and a private placement of approximately 5 million shares ... Under the terms of the reverse merger, ... Inc. will trade on the OTC Markets under the ...
(Date:5/4/2016)... Research and Markets has ... lymphocytic Leukemia Market and Competitive Landscape Highlights ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... and Competitive Landscape Highlights 2016, provides comprehensive ... Acute Lymphocytic Leukemia epidemiology, Acute Lymphocytic Leukemia ...
Breaking Medicine Technology:
(Date:5/4/2016)... , ... May 04, 2016 , ... Level 10 Head ... her verbal commitment to the University of Arizona for the fall of 2019. ... decision last month. Brovedani’s commitment to the GymCats came from her connection with the ...
(Date:5/4/2016)... ... ... The Spiritual Care Association (SCA) has declared May 10, 2016 ... and their families, and their overall contribution to the health care system. It will ... sent “Thank You Chaplain” cards with hand-painted artwork to about 10,000 chaplains and pastoral ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star Insurance of ... assist the people of their local community. The agency pledges to select a ... Their hope is to bring awareness to important local causes with fundraising and ...
(Date:5/4/2016)... ... May 04, 2016 , ... Momsense, Inc. ... The company’s patented technology, The Smart Breastfeeding Meter, is designed to monitor and ... technology is now available for purchase at Target.com . , Breastfeeding ...
(Date:5/4/2016)... Plainsboro, NJ (PRWEB) , ... May 04, 2016 ... ... for pharmacists and the pharmacy industry, today announced that it was chosen as ... Purchasing Alliance (APPA) Industry Awards . The awards acknowledge the hard work and ...
Breaking Medicine News(10 mins):